Antihypertensive dose-response relationships: Studies with the selective α1-blocking agent terazosin

American Heart Journal

Volumn 122, Issue 3 PART 2, 1991, Pages 905-910

  Weber, Michael A ^a,b,c   Cheung, Deanna G ^a,b,c   Laddu, Atul R ^a,b,c   Luther, Robert R ^a,b,c  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TERAZOSIN;

ADULT; AGED; BLOOD PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADRENERGIC ALPHA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORS; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; PRAZOSIN;

EID: 0025873703     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(91)90810-5     Document Type: Article

References (9)

1. Terazosin: an effective once-daily monotherapy for the treatment of hypertension
2. Overall safety of terazosin as an antihypertensive agent
3. Antihypertensive effects of β-blockers administered once daily: 24-hour measurements
4. Documentation of the effective length of action of antihypertensive treatment
5. The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents
6. Assessing duration of antihypertensive effects with whole-day blood pressure monitoring
7. Ambulatory blood pressure in relation to drug treatment and clinical trials
8. Long-term BP monitoring in the evaluation of antihypertensive therapy